Cargando…
Potential impact of subsequent entry biologics in nephrology practice in Canada
PURPOSE OF REVIEW: Subsequent entry biologics may soon be a reality in Canadian nephrology practice. Along with opportunities to reduce health care costs, these agents pose unique challenges that must be met for successful implementation. Understanding the experiences around the globe in both regula...
Autores principales: | Martinusen, Daniel J, Lo, Clifford, Marin, Judith G, Tsao, Nicole W, Leung, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349237/ https://www.ncbi.nlm.nih.gov/pubmed/25780621 http://dx.doi.org/10.1186/s40697-014-0032-7 |
Ejemplares similares
-
Efficacy and safety data of subsequent entry biologics pertinent to nephrology practice: a systematic review
por: Marin, Judith Genevieve, et al.
Publicado: (2014) -
A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada
por: Tsao, Nicole W, et al.
Publicado: (2014) -
A Review of Cannabis in Chronic Kidney Disease Symptom Management
por: Ho, Claudia, et al.
Publicado: (2019) -
Redesigning Kidney Care for the Anthropocene: A New Framework for Planetary
Health in Nephrology
por: Rajan, Tasleem, et al.
Publicado: (2022) -
Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study
por: Kaspar, Cristin D. W., et al.
Publicado: (2018)